Lbmc Investment Advisors LLC Sells 998 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Lbmc Investment Advisors LLC lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 2.2% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 45,135 shares of the company’s stock after selling 998 shares during the period. HCA Healthcare accounts for approximately 1.1% of Lbmc Investment Advisors LLC’s holdings, making the stock its 15th biggest position. Lbmc Investment Advisors LLC’s holdings in HCA Healthcare were worth $13,547,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. FMR LLC grew its stake in HCA Healthcare by 322.3% during the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after acquiring an additional 2,397,883 shares in the last quarter. Franklin Resources Inc. increased its holdings in shares of HCA Healthcare by 11.7% in the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock worth $660,842,000 after purchasing an additional 174,946 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in HCA Healthcare by 2.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock valued at $604,511,000 after buying an additional 41,190 shares in the last quarter. Janus Henderson Group PLC boosted its position in shares of HCA Healthcare by 12.0% during the 3rd quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock valued at $544,467,000 after acquiring an additional 143,995 shares during the last quarter. Finally, Darsana Capital Partners LP raised its stake in HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after purchasing an additional 400,000 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Cantor Fitzgerald restated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Morgan Stanley lowered their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. TD Cowen lowered their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. KeyCorp reduced their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Finally, Truist Financial reduced their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $385.27.

Insiders Place Their Bets

In other news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is owned by company insiders.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $310.60 on Friday. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 12 month low of $278.50 and a 12 month high of $417.14. The stock’s fifty day moving average price is $316.69 and its 200-day moving average price is $352.78. The firm has a market cap of $78.68 billion, a P/E ratio of 13.95, a P/E/G ratio of 1.03 and a beta of 1.64.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were paid a dividend of $0.66 per share. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.85%. HCA Healthcare’s dividend payout ratio is presently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.